Real World COPD: Association of Morning Symptoms with Clinical and Patient Reported Outcomes

被引:47
作者
Roche, Nicolas [1 ]
Small, Mark [2 ]
Broomfield, Sarah [2 ]
Higgins, Victoria [2 ]
Pollard, Ryan [2 ]
机构
[1] Univ Paris 05, Hop Cochin, Serv Pneumol & Reanimat, F-75005 Paris, France
[2] Adelphi Real World, Macclesfield, Cheshire, England
关键词
CAT score; daily activity; exacerbations; morning symptoms; symptom variability; OBSTRUCTIVE PULMONARY-DISEASE; ONCE-DAILY NVA237; IMPACT;
D O I
10.3109/15412555.2013.844784
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
This research examined the prevalence of morning symptoms and their relationship with health status, exacerbations and daily activity in patients with chronic obstructive pulmonary disease (COPD). Data on 1489 patients were analysed from a European and USA sample. Results were tested for significance (p < 0.05) using Mann-Whitney and regression modelling accounting for age, gender, body mass index, comorbidities, symptom severity, smoking status and medication adherence. Morning symptoms were experienced by 39.8% of patients. Controlling for potential confounders, morning symptoms were significantly associated with higher COPD assessment test scores (p < 0.001) and exacerbation frequency (p < 0.001), more frequent worsening of symptoms without consulting a Health Care Professional (p = 0.008), and increased impact on normal daily activities (p = 0.007); and in the working population, a significantly greater impact on getting up and ready for the day (p < 0.001) and significantly more days off work per year (p < 0.001). Our research concluded that in patients with COPD, morning symptoms are associated with poorer health status, impaired daily activities and increased risk of exacerbation in affected patients compared with those patients without morning symptoms. Improved control of patients' morning symptoms may lead to substantial reduction in COPD impact and frequency of exacerbations, and enable patients to increase daily activities, particularly early morning activities. This could, in turn, enable working patients with COPD to be more productive in the workplace.
引用
收藏
页码:679 / 686
页数:8
相关论文
共 25 条
[1]   Real-world physician and patient behaviour across countries: Disease-Specific Programmes - a means to understand [J].
Anderson, P. ;
Benford, M. ;
Harris, N. ;
Karavali, M. ;
Piercy, J. .
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) :3063-3072
[2]  
[Anonymous], 2012, STAT STAT SOFTW REL
[3]  
[Anonymous], 2009, SUMM HIPAA PRIV RUL
[4]   Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial [J].
Beeh, Kai M. ;
Singh, Dave ;
Di Scala, Lilla ;
Drollmann, Anton .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 7 :503-513
[5]   International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study [J].
Buist, A. Sonia ;
McBurnie, Mary Ann ;
Vollmer, William M. ;
Gillespie, Suzanne ;
Burney, Peter ;
Mannino, David M. ;
Menezes, Ana M. B. ;
Sullivan, Sean D. ;
Lee, Todd A. ;
Weiss, Kevin B. ;
Jensen, Robert L. ;
Marks, Guy B. ;
Gulsvik, Amund ;
Nizankowska-Mogilnicka, Ewa .
LANCET, 2007, 370 (9589) :741-750
[6]   Cough and Sputum Production Are Associated With Frequent Exacerbations and Hospitalizations in COPD Subjects [J].
Burgel, Pierre-Regis ;
Nesme-Meyer, Pascale ;
Chanez, Pascal ;
Caillaud, Denis ;
Carre, Philippe ;
Peres, Thierry ;
Roche, Nicolas .
CHEST, 2009, 135 (04) :975-982
[7]   Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial [J].
D'Urzo, Anthony ;
Ferguson, Gary T. ;
van Noord, Jan A. ;
Hirata, Kazuto ;
Martin, Carmen ;
Horton, Rachael ;
Lu, Yimeng ;
Banerji, Donald ;
Overend, Tim .
RESPIRATORY RESEARCH, 2011, 12
[8]   A study of the Effect of Proinflammatory Cytokines on the Epithelial Cells of Smokers, with or without COPD [J].
De Diego Damia, Alfredo ;
Cortijo Gimeno, Julio ;
Selma Ferrer, M. Jose ;
Leon Fabregas, Montserral ;
Almudever Folch, Patricia ;
Milara Paya, Javier .
ARCHIVOS DE BRONCONEUMOLOGIA, 2011, 47 (09) :447-453
[9]  
ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321
[10]  
European Society for Opinion and Marketing Research (ESOMAR), INT COD MARK SOC RES